Welcome to Pierre Desaulniers Ing. who joins the group for a technology maturation project where three patents from the Research Centre will be transferred to BLIQc, a microscopy company. He comes from the group of NSERC Industrial Chair of Optics Design Professor Simon Thibault from Laval University where he was research associate.
Congratulations to Soon-to-be Doctor Erik Bélanger who received one of the 20 Canadian post-doctoral Fellowships by MS Canada. He will be joining Prof. Yves De Koninck’s laboratory to continue his work in the field of Multiple Sclerosis Research.
You can read the official announcement here.
We are very pleased to have been awarded a Canada Excellence Research Chair in Neurophotonics for 10M$ from the Canadian Government over 7 years. The focus is innovative optical technologies in neurosciences.
New non-invasive approaches, technologies, and instruments will enable the Chair in Neurophotonics to study the mysteries of the brain in the context of Alzheimer’s disease, Lou Gehrig’s disease, epilepsy and depression, as well as other disorders and diseases. By fostering the development of key advances in understanding brain function and enhancing neurosurgery and pharmacological resources, the Chair will help confirm Quebec City’s leadership in photonics, neuroscience and mental health, and will fuel innovative breakthroughs in biomedical technology.
Profs Yves De Koninck, Daniel Côté, Réal Vallée, and Antoine Adamantidis have received one of the three FRQS-Pfizer grants entitled “Douleur chronique et maladies mentales : nouvelles technologies pour l’identification et la validation de cibles thérapeutiques par dissection optique” for $600,000 over three years.
Prof. Côté and collaborators Profs. Younès Messaddeq, Tigran Galstian, Martin Parent, neurosurgeons Drs Léo Cantin and Michel Prudhomme and their partner Genia Photonics were awarded a 3-year grant of $600,000 from NSERC and CIHR’s Collaborative Health Research Grant program on “Optical guidance during neurosurgery for deep brain stimulation electrode implantation in the treatment of Parkinson’s disease”.